ライフサイエンスコーパス: screening system

1 olated using a newly established yeast-based screening system.

2 protein using a bacterial two-hybrid library screening system.

3 m, and L. monocytogenes in food samples as a screening system.

4 ytidine (5Aza-dC)-induced senescence bypass) screening system.

5 have employed an Alu-PCR-based hybridization screening system.

6 hlamydial serovars was used for testing this screening system.

7 and the lack of rapid, sensitive biological screening systems.

8 high-throughput genomics and innovative drug-screening systems.

9 very of therapeutic compounds through simple screening systems.

10 are most commonly applied in high-throughput screening systems.

11 uch as clinical analysis and high-throughput screening systems.

12 Through phenotypic screening, systems analysis, and rigorous experimental v

13 A expression library in the yeast one-hybrid screening system and obtained the cDNA clone NT2.

14 red nanoparticles (ENP) in a high-throughput screening system and places this model in an adverse out

15 It is an ideal technique for high-throughput screening systems and demonstrates the power of lab-on-a

16 High-throughput cell-culture screening systems are also being developed.

17 less developed countries where no effective screening systems are available.

18 Here, using a systemic screening system based on a luciferase reporter gene ass

19 We built a fully automated cell culture screening system based on a microfluidic chip that creat

20 Using a mammalian screening system based on transcriptional activation by

21 e report the development of an antifiloviral screening system, based on a pseudotyping strategy, and

22 Testing of the PCR screening system confirmed it to be highly specific and

23 Thus, our novel screening system could be a useful tool to identify and

24 We present an ultra-sensitive screening system coupled to an ex vivo prion organotypic

25 Such a screening system detects even low levels of protein spli

26 This screening system does not require deep sequencing and ma

27 A high-throughput screening system for homogeneous catalyst discovery has

28 We have set up a yeast growth-based screening system for mutant D-xylose transporters that a

29 e interaction with the enzyme and a powerful screening system for new inhibitors.

30 ssay should be valuable as a high-throughput screening system for protein splicing inhibitors as pote

31 munosorbent assay (ELISA) was developed as a screening system for rapid detection of clenbuterol, whi

32 lished a robust and specific high-throughput screening system for synthetic defense elicitors that ca

33 Thus, we have developed a microarray-based screening system for testing the effects of small molecu

34 To establish a screening system for the humoral response to autoimmunog

35 In this paper, we describe an in vivo screening system for the isolation of mutations or inhib

36 New screening systems for enantioselectivity and protein sol

37 ll as for novel versatile agonist/antagonist screening systems for identification of novel therapeuti

38 With respect to the needs of productive screening systems for robust and reproducible measuremen

39 The automated screening system had a sensitivity of 97.6% (95% confide

40 he performance of the Cellenium 160 US urine screening system in comparison to that of the semiquanti

41 lustrate the ability of direct combinatorial screening systems in cancer patients for identification

42 the full capabilities of our high-throughput screening system, including generation of spectroscopic

43 ificity, we developed an unbiased cell-based screening system involving multiple rounds of infection

44 Thus, developing an appropriate in vitro screening system is critical to prioritize which of the

45 lying a computational workflow for parameter screening, systems modeling identified that apoptosis ex

46 Our proof-of-concept experiments verify the screening system of farm-derived dust samples as suitabl

47 The model provides a rapid method for screening system parameters for the potential to mediate

48 ved human p53 mutants, (b) demonstrating the screening system's efficiency through identification of

49 By using a high-throughput screening system targeting host protein kinases, we iden

50 ch has been impaired by the lack of a robust screening system that can be used to investigate interac

51 ed an in vivo Drosophila X virus (DXV)-based screening system that identifies altered sensitivity to

52 Our findings describe a new screening system that identifies molecules and pathways

53 Establishing state-of-the-art screening systems that rely on fluorescent or luminescen

54 tifying patients most likely to benefit from screening, systems that facilitate their application, an

55 aromyces cerevisiae was also used as a rapid screening system to evaluate tomato antioxidant capacity

56 t study we employed a yeast-based two-hybrid screening system to identify BAT3 (HLA-B-associated tran

57 cells and established a flow cytometry-based screening system to identify compounds that increase MBN

58 genesis and a retrovirus-mediated expression screening system to identify constitutively active forms

59 ll death we have designed a loss-of-function screening system to identify genes that are essential fo

60 We have developed and used a Drosophila screening system to identify genes that are functionally

61 ition of Saccharomyces cerevisiae as a model screening system to identify human genes that regulate c

62 n inexpensive nonradioactive high-throughput screening system to identify new ACC inhibitors.

63 We have used a FACS-based genome-wide screening system to identify transcriptional alterations

64 s into apoE biology and establishes a robust screening system to monitor apoE conformation.

65 Hence, development of a high-throughput screening system to monitor temporal changes of IP(3) is

66 A multiplexed screening system to quickly determine the binding affini

67 on by KSHV, we used two different gene array screening systems to examine the expression profile of e

68 C. elegans has been used in mutation-based screening systems to identify novel virulence-related mi

69 Screening systems to identify receptors for RvD1 gave tw

70 V-MP) were used, in a modified phage-display screening system, to identify peptides capable of intera

71 Most applications in droplet microfluidic screening systems use fluorogenic substrates to measure

72 on was examined by a cell-based high content screening system using LysoTracker, which was followed b

73 The feasibility of the screening system was confirmed by constructing a protein

74 A high throughput screening system was developed to measure H(2)O(2)-suppo

75 The applicability of the screening system was evaluated by analysis of various ty

76 el bacterial display/flow cytometric library screening system we isolated Fc variants that bind to Fc

77 Using the screening system, we have established conditions under w

78 Using a yeast two-hybrid screening system, we have identified Ral-binding protein

79 Using the yeast two-hybrid screening system, we have isolated and characterized the

80 man liver cDNA library in a yeast two-hybrid screening system, we have isolated several positive clon

81 Using a newly developed high-throughput screening system, we identified inhibitors and activator

82 Using a yeast genetic screening system, we identify Lhx3 point mutants that bi

83 In the in vitro screening systems, we demonstrated that 1) anti-CD105 (E

84 volume; compared to state-of-the-art robotic screening systems, we perform the entire assay with a 1,

85 We anticipate that the CcdB-based in vivo screening system will find uses in the analysis of struc

86 a novel surface display Y2H (sdY2H) library screening system with uniquely integrated surface displa

87 Such a screening system yielded a plasmid with a 4.8-kb insert.